	판매 매출 총 이익		날짜
AbbVie	USD 14.39B	1.85B	2026-06
Amgen	USD 5.87B	1.02B	2026-03
Anika Therapeutics	USD 19.18M	3.6M	2025-12
Arrowhead Research	USD 75.25M	1.52M	2026-06
AstraZeneca	USD 12.86B	251M	2026-06
BioCryst Pharmaceuticals	USD 214.41M	61.36M	2026-06
Biogen	USD 2.12B	307M	2026-06
Bristol-Myers Squibb	USD 9.26B	1.19B	2026-06
Enanta Pharmaceuticals	-22.29M	23.75M	2024-12
Gilead Sciences	USD 6.8B	1.29B	2026-06
GlaxoSmithKline	GBP 6.51B	757M	2026-06
Halozyme Therapeutics	USD 297.47M	75.53M	2026-03
Heron Therapeutics	USD 29.47M	3.17M	2025-12
Immunic	0	0	2025-03
Incyte	USD 1.57B	400.89M	2026-06
Insmed	USD 356.19M	99.73M	2026-06
Ionis Pharmaceuticals	USD 265M	22M	2026-06
J&J	USD 18.55B	1.31B	2026-06
Karyopharm Therapeutics	USD 33.72M	1.13M	2026-03
Ligand Pharmaceuticals	USD 100.41M	51.96M	2026-06
Merck	USD 12.09B	1.24B	2026-03
Neurocrine Biosciences	USD 800.7M	12.8M	2026-03
Novartis	USD 11.24B	1.18B	2026-06
Novavax	USD 125.04M	76.09M	2025-12
Pfizer	USD -248M	11.29B	2026-06
PTC Therapeutics	USD 232.94M	84.56M	2026-03
Roche Holding	CHF 22.69B	600M	2026-06
Sarepta Therapeutics	USD 251.15M	370.2M	2026-06
Vertex Pharmaceuticals	USD 2.84B	242.4M	2026-06